MND Trial Completes Enrolment of First Patient Cohort (final) Category: News & Announcements 2022By PharmAustDecember 2, 2022Related postsFireside chat with Dr KimDecember 23, 2022PharmAust Canine Trial UpdateDecember 20, 2022PharmAust Receives R&D Tax Incentive RefundDecember 12, 2022PhamAust WebinarNovember 17, 2022PhamAust AGM 2022November 11, 2022PharmAust doses first patient with MPL in motor neurone disease trialOctober 3, 2022